ID

35581

Beschreibung

Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM); ODM derived from: https://clinicaltrials.gov/show/NCT02457130

Link

https://clinicaltrials.gov/show/NCT02457130

Stichworte

  1. 11.03.19 11.03.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

11. März 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Coronary Artery Disease NCT02457130

Eligibility Coronary Artery Disease NCT02457130

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of informed consent prior to any study specific procedures
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
age between 18 and 75 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
type 2 dm according to ada criteria
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
angiographically documented cad
Beschreibung

Coronary Artery Disease Angiography

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C0002978
chronic treatment (>1 month) with aspirin (100mg/day)
Beschreibung

Aspirin chronic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0205191
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
known allergies to aspirin, clopidogrel, or ticagrelor
Beschreibung

Aspirin allergy | Hypersensitivity Clopidogrel | Hypersensitivity Ticagrelor

Datentyp

boolean

Alias
UMLS CUI [1]
C0004058
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0070166
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C1999375
blood dyscrasia
Beschreibung

Hematological Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0018939
any recent acute coronary syndrome (<30 days) or hemodinamic instability
Beschreibung

Acute Coronary Syndrome | Hemodynamic instability

Datentyp

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2]
C0948268
recent antiplatelet therapy (<14 days), with the exception of asa, including: thienopyridines, cilostazol, dipiridamol, glycoprotein iib/iiia inhibitors
Beschreibung

Antiplatelet therapy | Exception Aspirin | Thienopyridines | cilostazol | Dipyridamole | Platelet Glycoprotein IIb/IIIA Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C1096021
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0004057
UMLS CUI [3]
C2936588
UMLS CUI [4]
C0055729
UMLS CUI [5]
C0012582
UMLS CUI [6]
C1373125
oral anticoagulation with a coumarin derivative
Beschreibung

Anticoagulation Therapy Oral | Coumarin Derivative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003281
UMLS CUI [1,2]
C1527415
UMLS CUI [2,1]
C0010206
UMLS CUI [2,2]
C1527240
concomitant treatment with a potent cyp3a4 inhibitor (e.g. ketoconazole, claritromicine, nefazodone, ritonavir, atazanavir)
Beschreibung

CYP3A4 Inhibitor | Ketoconazole | Clarithromycin | nefazodone | Ritonavir | Atazanavir

Datentyp

boolean

Alias
UMLS CUI [1]
C3830624
UMLS CUI [2]
C0022625
UMLS CUI [3]
C0055856
UMLS CUI [4]
C0068485
UMLS CUI [5]
C0292818
UMLS CUI [6]
C1145759
any active bleeding
Beschreibung

Hemorrhage

Datentyp

boolean

Alias
UMLS CUI [1]
C0019080
recent history of stroke, tia or intracranial bleeding (<6 months prior to inclusion)
Beschreibung

Cerebrovascular accident | Transient Ischemic Attack | Intracranial Hemorrhages

Datentyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0007787
UMLS CUI [3]
C0151699
platelet count <100x106/microl
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
severe chronic kidney disease (creatinine clearance measured with cockcroft-gault formula <30ml/min)
Beschreibung

Chronic Kidney Disease Severe | Estimation of creatinine clearance by Cockcroft-Gault formula

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C2711451
any active neoplasm
Beschreibung

Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1]
C0027651
baseline alt >2.5 times the upper limit of normality
Beschreibung

Alanine aminotransferase increased

Datentyp

boolean

Alias
UMLS CUI [1]
C0151905
pregnant or childbearing females
Beschreibung

Pregnancy | Childbirth

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C1148523

Ähnliche Modelle

Eligibility Coronary Artery Disease NCT02457130

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
provision of informed consent prior to any study specific procedures
boolean
C0021430 (UMLS CUI [1])
Age
Item
age between 18 and 75 years
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 dm according to ada criteria
boolean
C0011860 (UMLS CUI [1])
Coronary Artery Disease Angiography
Item
angiographically documented cad
boolean
C1956346 (UMLS CUI [1,1])
C0002978 (UMLS CUI [1,2])
Aspirin chronic
Item
chronic treatment (>1 month) with aspirin (100mg/day)
boolean
C0004057 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Aspirin allergy | Hypersensitivity Clopidogrel | Hypersensitivity Ticagrelor
Item
known allergies to aspirin, clopidogrel, or ticagrelor
boolean
C0004058 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0070166 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C1999375 (UMLS CUI [3,2])
Hematological Disease
Item
blood dyscrasia
boolean
C0018939 (UMLS CUI [1])
Acute Coronary Syndrome | Hemodynamic instability
Item
any recent acute coronary syndrome (<30 days) or hemodinamic instability
boolean
C0948089 (UMLS CUI [1])
C0948268 (UMLS CUI [2])
Antiplatelet therapy | Exception Aspirin | Thienopyridines | cilostazol | Dipyridamole | Platelet Glycoprotein IIb/IIIA Inhibitors
Item
recent antiplatelet therapy (<14 days), with the exception of asa, including: thienopyridines, cilostazol, dipiridamol, glycoprotein iib/iiia inhibitors
boolean
C1096021 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C2936588 (UMLS CUI [3])
C0055729 (UMLS CUI [4])
C0012582 (UMLS CUI [5])
C1373125 (UMLS CUI [6])
Anticoagulation Therapy Oral | Coumarin Derivative
Item
oral anticoagulation with a coumarin derivative
boolean
C0003281 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0010206 (UMLS CUI [2,1])
C1527240 (UMLS CUI [2,2])
CYP3A4 Inhibitor | Ketoconazole | Clarithromycin | nefazodone | Ritonavir | Atazanavir
Item
concomitant treatment with a potent cyp3a4 inhibitor (e.g. ketoconazole, claritromicine, nefazodone, ritonavir, atazanavir)
boolean
C3830624 (UMLS CUI [1])
C0022625 (UMLS CUI [2])
C0055856 (UMLS CUI [3])
C0068485 (UMLS CUI [4])
C0292818 (UMLS CUI [5])
C1145759 (UMLS CUI [6])
Hemorrhage
Item
any active bleeding
boolean
C0019080 (UMLS CUI [1])
Cerebrovascular accident | Transient Ischemic Attack | Intracranial Hemorrhages
Item
recent history of stroke, tia or intracranial bleeding (<6 months prior to inclusion)
boolean
C0038454 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
C0151699 (UMLS CUI [3])
Platelet Count measurement
Item
platelet count <100x106/microl
boolean
C0032181 (UMLS CUI [1])
Chronic Kidney Disease Severe | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
severe chronic kidney disease (creatinine clearance measured with cockcroft-gault formula <30ml/min)
boolean
C1561643 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C2711451 (UMLS CUI [2])
Neoplasms
Item
any active neoplasm
boolean
C0027651 (UMLS CUI [1])
Alanine aminotransferase increased
Item
baseline alt >2.5 times the upper limit of normality
boolean
C0151905 (UMLS CUI [1])
Pregnancy | Childbirth
Item
pregnant or childbearing females
boolean
C0032961 (UMLS CUI [1])
C1148523 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video